UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm

Current opinion in neurology, 2019-06, Vol.32 (3), p.365-377

2019

Volltextzugriff (PDF)

Multiple sclerosis and COVID-19

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2020-09, Vol.164 (3), p.217-225

2020

Volltextzugriff (PDF)

Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change

Current opinion in neurology, 2019-06, Vol.32 (3), p.327-337

2019

Volltextzugriff (PDF)

Prognostic relevance of the C‐X‐C motif chemokine ligand 13 and interleukin‐8 in predicting the transition from clinically isolated syndrome to multiple sclerosis

The European journal of neuroscience, 2024-06, Vol.59 (11), p.2955-2966

2024

Volltextzugriff (PDF)

Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis

Frontiers in neurology, 2020-09, Vol.11, p.944-944

2020

Volltextzugriff (PDF)

B cell targeted therapies in inflammatory autoimmune disease of the central nervous system

Frontiers in immunology, 2023-03, Vol.14, p.1129906-1129906

2023

Volltextzugriff (PDF)

Multimodal-neuroimaging machine-learning analysis of motor disability in multiple sclerosis

Brain imaging and behavior, 2023-02, Vol.17 (1), p.18-34

2023

Volltextzugriff (PDF)

An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart

Expert opinion on drug delivery, 2020-05, Vol.17 (5), p.719-724

2020

Volltextzugriff (PDF)

Changes in oxygen saturation and the retinal nerve fibre layer in patients with optic neuritis associated with multiple sclerosis in a 6‐month follow‐up

Acta ophthalmologica (Oxford, England), 2020-12, Vol.98 (8), p.841-847

2020

Volltextzugriff (PDF)

Changes in oxygen saturation and the retinal nerve fibre layer in patients with optic neuritis – a pilot study

Acta ophthalmologica (Oxford, England), 2018-05, Vol.96 (3), p.e309-e314

2018

Volltextzugriff (PDF)

A Three-Arm Parallel-group Exploratory Trial documents balance improvement without much evidence of white matter integrity changes in people with multiple sclerosis following two months ambulatory neuroproprioceptive "facilitation and inhibition" physical therapy

European journal of physical and rehabilitation medicine, 2021-12, Vol.57 (6), p.889

2021

Volltextzugriff (PDF)

Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS

Frontiers in neurology, 2021-01, Vol.11, p.593527-593527

2021

Volltextzugriff (PDF)

Prognostic value of cerebrospinal fluid biomarkers in multiple sclerosis: The key role of kappa free light chains and a multivariate predictor for disease progression

Multiple sclerosis and related disorders, 2024-02, Vol.82, p.105402-105402, Article 105402

2024

Volltextzugriff (PDF)

Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management

Neurotherapeutics, 2022-04, Vol.19 (3), p.753-773

2022

Volltextzugriff (PDF)

Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options – Review Article

Neuropsychiatric disease and treatment, 2023-11, Vol.19, p.2485-2497

2023

Volltextzugriff (PDF)

Drug-induced systemic lupus erythematosus in interferon beta-1b therapy

Neuro-endocrinology letters, 2011, Vol.32 (1), p.4-6

2011

Volltextzugriff (PDF)

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis

The New England journal of medicine, 2019-06, Vol.380 (25), p.2406-2417

2019

Volltextzugriff (PDF)

Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis

Journal of the neurological sciences, 2014-07, Vol.342 (1), p.62-68

2014

Volltextzugriff (PDF)

Alemtuzumab: Rare serious adverse events of a high-efficacy drug

Multiple sclerosis, 2020-05, Vol.26 (6), p.737-740

2020

Volltextzugriff (PDF)

Multiple Sclerosis: Switching from Natalizumab to Other High-Efficacy Treatments to Mitigate Progressive Multifocal Leukoencephalopathy Risk

Neurotherapeutics, 2021-07, Vol.18 (3), p.1654-1656

2021

Volltextzugriff (PDF)

Drug Treatment of Clinically Isolated Syndrome

CNS drugs, 2019-07, Vol.33 (7), p.659-676

2019

Volltextzugriff (PDF)

Managing Risks with Immune Therapies in Multiple Sclerosis

Drug safety, 2019-05, Vol.42 (5), p.633-647

2019

Volltextzugriff (PDF)

Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome

Neurological research (New York), 2011-05, Vol.33 (4), p.415-420

2011

Volltextzugriff (PDF)

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

Multiple sclerosis and related disorders, 2023-08, Vol.76, p.104803-104803, Article 104803

2023

Volltextzugriff (PDF)

Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic

Multiple sclerosis and related disorders, 2022-03, Vol.59, p.103391-103391, Article 103391

2022

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaMultiple Sclerosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(21)
Neurosciences & Neurology
(19)
Clinical Neurology
(15)
Neurosciences
(15)
Female
(9)
Multiple Sclerosis - Drug Therapy
(9)
Adult
(8)
Neurology
(8)
Pharmacology & Pharmacy
(6)
Magnetic Resonance Imaging
(5)
Male
(5)
Middle Aged
(5)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(5)
Patients
(5)
Central Nervous System
(4)
Monoclonal Antibodies
(4)
Pregnancy
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm

Multiple sclerosis and COVID-19

Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change

Prognostic relevance of the C‐X‐C motif chemokine ligand 13 and interleukin‐8 in predicting the transition from clinically isolated syndrome to multiple sclerosis

Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis

B cell targeted therapies in inflammatory autoimmune disease of the central nervous system

Multimodal-neuroimaging machine-learning analysis of motor disability in multiple sclerosis

An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart

Changes in oxygen saturation and the retinal nerve fibre layer in patients with optic neuritis associated with multiple sclerosis in a 6‐month follow‐up

Changes in oxygen saturation and the retinal nerve fibre layer in patients with optic neuritis – a pilot study

A Three-Arm Parallel-group Exploratory Trial documents balance improvement without much evidence of white matter integrity changes in people with multiple sclerosis following two months ambulatory neuroproprioceptive "facilitation and inhibition" physical therapy

Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS

Prognostic value of cerebrospinal fluid biomarkers in multiple sclerosis: The key role of kappa free light chains and a multivariate predictor for disease progression

Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management

Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options – Review Article

Drug-induced systemic lupus erythematosus in interferon beta-1b therapy

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis

Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis

Alemtuzumab: Rare serious adverse events of a high-efficacy drug

Multiple Sclerosis: Switching from Natalizumab to Other High-Efficacy Treatments to Mitigate Progressive Multifocal Leukoencephalopathy Risk

Drug Treatment of Clinically Isolated Syndrome

Managing Risks with Immune Therapies in Multiple Sclerosis

Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic

Aktive Filter

Suchergebnisse filtern